| Jennifer Kelley, MD | |
|
6675 Holmes Rd, Ste 360, Kansas City, MO 64131-1150 | |
| (816) 276-7600 | |
| (816) 276-7992 |
| Full Name | Jennifer Kelley |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 6675 Holmes Rd, Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710920210 | NPI | - | NPPES |
| 100388320B | Medicaid | KS | |
| 205208713 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 113171 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Research Medical Center | Kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Goppert - Trinity Family Care, Llc | 8426956681 | 11 |
News Archive
Today the Global Healthy Living Foundation (GHLF) and CreakyJoints®, its digital patient community for people with all forms of arthritis, announced the launch of the Autoimmune COVID-19 Project.
Depomed, Inc. today announced top line results from the Phase III clinical trial of its Ciprofloxacin GR, an extended release formulation of ciprofloxacin HCl, which is used to treat urinary tract infections. The data confirmed Phase II results, demonstrating that Depomed's once-daily Ciprofloxacin GR eliminated the organisms responsible for urinary tract infections as effectively as twice-daily CIPRO(R), but with fewer gastrointestinal side effects, specifically fewer incidences of nausea and diarrhea.
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
Training materials that are accessible and easy to understand contribute to an overall increase in satisfaction among adults or parents of children with Type 1 or Type 2 diabetes who use a blood glucose meter, and satisfaction is significantly higher when they understand how to use their meter, according to the J.D. Power 2015 U.S. Blood Glucose Meter Satisfaction Study.
› Verified 6 days ago
| Entity Name | Goppert - Trinity Family Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922097013 PECOS PAC ID: 8426956681 Enrollment ID: O20031224000034 |
News Archive
Today the Global Healthy Living Foundation (GHLF) and CreakyJoints®, its digital patient community for people with all forms of arthritis, announced the launch of the Autoimmune COVID-19 Project.
Depomed, Inc. today announced top line results from the Phase III clinical trial of its Ciprofloxacin GR, an extended release formulation of ciprofloxacin HCl, which is used to treat urinary tract infections. The data confirmed Phase II results, demonstrating that Depomed's once-daily Ciprofloxacin GR eliminated the organisms responsible for urinary tract infections as effectively as twice-daily CIPRO(R), but with fewer gastrointestinal side effects, specifically fewer incidences of nausea and diarrhea.
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
Training materials that are accessible and easy to understand contribute to an overall increase in satisfaction among adults or parents of children with Type 1 or Type 2 diabetes who use a blood glucose meter, and satisfaction is significantly higher when they understand how to use their meter, according to the J.D. Power 2015 U.S. Blood Glucose Meter Satisfaction Study.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Kelley, MD 6675 Holmes Rd, Ste 450, Kansas City, MO 64131-1150 Ph: (816) 276-7600 | Jennifer Kelley, MD 6675 Holmes Rd, Ste 360, Kansas City, MO 64131-1150 Ph: (816) 276-7600 |
News Archive
Today the Global Healthy Living Foundation (GHLF) and CreakyJoints®, its digital patient community for people with all forms of arthritis, announced the launch of the Autoimmune COVID-19 Project.
Depomed, Inc. today announced top line results from the Phase III clinical trial of its Ciprofloxacin GR, an extended release formulation of ciprofloxacin HCl, which is used to treat urinary tract infections. The data confirmed Phase II results, demonstrating that Depomed's once-daily Ciprofloxacin GR eliminated the organisms responsible for urinary tract infections as effectively as twice-daily CIPRO(R), but with fewer gastrointestinal side effects, specifically fewer incidences of nausea and diarrhea.
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
Training materials that are accessible and easy to understand contribute to an overall increase in satisfaction among adults or parents of children with Type 1 or Type 2 diabetes who use a blood glucose meter, and satisfaction is significantly higher when they understand how to use their meter, according to the J.D. Power 2015 U.S. Blood Glucose Meter Satisfaction Study.
› Verified 6 days ago
George Wesley Roodhouse, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 6675 Holmes Rd Ste 360, Kansas City, MO 64131 Phone: 816-276-7650 Fax: 816-276-7992 | |
Sabrina Diane Knoch, FNP-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 Nw 68th St, Kansas City, MO 64118 Phone: 816-420-6300 | |
Dr. Avery Thomas Abernathy, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6450 N Chatham Ave, Kansas City, MO 64151 Phone: 816-741-5542 Fax: 816-746-4262 | |
Rance Mcclain, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1010 Carondelet Dr, Suite #220, Kansas City, MO 64114 Phone: 816-941-1600 Fax: 816-941-1699 | |
Dr. Valerie Lynn Duff, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6675 Holmes Rd Suite 360, Kansas City, MO 64131 Phone: 816-276-7600 | |
Dr. Heather Renee Bollinger, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5501 Nw 62nd Ter Ste 100, Kansas City, MO 64151 Phone: 816-842-4440 Fax: 816-842-1974 | |
Christopher Paul Trimble, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9784 N Ash Ave, Kansas City, MO 64157 Phone: 816-781-4244 Fax: 816-781-3542 |